Lifting agent granuloma presenting as a colonic mass mimicking cancer: a report of three cases

BACKGROUND: The Food and Drug Administration (FDA)-approved submucosal injection of lifting agents such as ORISE(®) has become a widespread, routine and standard practice in endoscopic mucosal resection and endoscopic submucosal dissection of gastrointestinal lesions. Lifting agent granulomas result...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendelson, Nicole L., Elliott, Kayla R., Evans, Krista E., Frisch, Nora K., Abu Alfa, Amer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929658/
https://www.ncbi.nlm.nih.gov/pubmed/36817705
http://dx.doi.org/10.21037/acr-22-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929658/
https://www.ncbi.nlm.nih.gov/pubmed/36817705
http://dx.doi.org/10.21037/acr-22-59

Ejemplares similares